{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T08:06:00Z","timestamp":1700035560908},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,12,2]],"date-time":"2005-12-02T00:00:00Z","timestamp":1133481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:p><jats:bold>BACKGROUND:\u2002<\/jats:bold> Peripheral blood progenitor cells (PBPCs) are often collected after mobilization with high\u2010dose cyclophosphamide (HDC) combined with growth factors. HDC may not be needed for PBPC mobilization, and patients with lymphoid malignancies can be harvested with treatment regimens of chemotherapy.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:\u2002<\/jats:bold> A retrospective analysis was performed on 141 patients with lymphoma or multiple myeloma whose PBPCs were harvested after chemotherapy. The PBPC yield and time to mobilization was compared between patients who received HDC (n\u2003=\u200351) and other chemotherapy regimens (n\u2003=\u200390) including high\u2010dose cyclophosphamide and etoposide (HDC plus VP\u201016; n\u2003=\u200341), CHOP, ESHAP, ABVD, VAD, and others (n\u2003=\u200349). A multiple linear regression model and proportional hazards model determined factors influencing yield and time to mobilization, respectively.<\/jats:p><jats:p><jats:bold>RESULTS:\u2002<\/jats:bold> The difference in mean yield between HDC and all non\u2010HDC regimens was significant, with HDC plus VP\u201016 resulting in the highest yields. The proportion of patients achieving a CD34 count in excess of 5\u2003\u00d7\u200310<jats:sup>6<\/jats:sup> per kg did not differ significantly between the regimens. In a multiple linear regression model, HDC plus VP\u201016 resulted in a higher PBPC yield than HDC but all other regimens did not. In addition, patients exposed to more than one prior chemotherapy regimen had lower yield regardless of the mobilization regimen. The mean number of days to mobilization with HDC was 10.2 days, 17.1\u2003days for HDC plus VP\u201016, and 14.2\u2003days for all other regimens. The timing of mobilization was influenced by the chemotherapy used and the number of prior regimens in a proportional hazards model.<\/jats:p><jats:p><jats:bold>CONCLUSION:\u2002<\/jats:bold> These results demonstrate a higher mean yield of PBPCs with HDC plus VP\u201016 but no difference in yield between non\u2010HDC plus VP\u201016 regimens used for first\u2010line or relapse therapy and HDC, suggesting that HDC may be an unnecessary additional therapy.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2006.00695.x","type":"journal-article","created":{"date-parts":[[2005,12,2]],"date-time":"2005-12-02T11:37:42Z","timestamp":1133523462000},"page":"174-179","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high\u2010dose cyclophosphamide: a retrospective review of 141 patients"],"prefix":"10.1111","volume":"46","author":[{"given":"Sarit","family":"Assouline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie\u2010Pierre","family":"Sylvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Carriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaim","family":"Shustik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Laneuville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700867"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.1998.16.4.1547","article-title":"Comparable engraftment kinetics following peripheral\u2010blood stem\u2010cell infusion mobilized with granulocyte colony\u2010stimulating factor with or without cyclophosphamide in multiple myeloma","volume":"6","author":"Desikan KR","year":"1998","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703912"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.7.2059"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702609"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703364"},{"issue":"1","key":"e_1_2_6_8_2","first-page":"Abstract","article-title":"A comparison of ESHAP and G\u2010CSF vs. cyclophosphamide 1.5 g\/m2 for PBSC mobilization in pre\u2010treated lymphoma patients: a matched pair analysis","volume":"88","author":"Watts MJ","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyg013"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701592"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00960.x"},{"key":"e_1_2_6_12_2","first-page":"4949","article-title":"Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease","volume":"86","author":"Canales MA","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_6_13_2","unstructured":"MoskowitzCH GlassmanJR WuestD et al.Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.Clin Cancer Res1998:311\u20106."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3433157.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F"},{"key":"e_1_2_6_16_2","first-page":"87","volume-title":"Modern epidemiology","author":"Rothman KJ","year":"1998"},{"key":"e_1_2_6_17_2","first-page":"192a","article-title":"High dose etoposide and cyclophosphamide therapy in refractory\/relapsed lymphomas\u2014an update of 85 patients [Abstract 849]","volume":"90","author":"Cohen S","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.12.3449.3449"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.1.214"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.00381.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.17.3771"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.3.814"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02955.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2006.00695.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2006.00695.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T03:18:52Z","timestamp":1697253532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2006.00695.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1111\/j.1537-2995.2006.00695.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2006.00695.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,2]]}}}